Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 2, 2004, Pages 186-192

  Pärsson, Håkan ^a,c   Holmberg, A ^a   Siegbahn, A ^b   Bergqvist, D ^a  

^a Institution for Surgical Science   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Department of Surgery ^*  (Sweden)

Author keywords

Coagulation; Critical limb ischemia; Fibrinolysis; Revascularisation

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR; CLOPIDOGREL; D DIMER; ENOXAPARIN; FIBRINOLYTIC FACTOR; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLITEF; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; FEMOROPOPLITEAL BYPASS; FIBRINOLYSIS; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; MALE; MEASUREMENT; PLASMINOGEN ACTIVATION; POLITEF IMPLANT; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPERFUSION; STATISTICAL SIGNIFICANCE; THROMBOSIS;

EID: 1642431756     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2003.10.015     Document Type: Article

References (28)

1. Speiser W, Speiser P, Minar E et al. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res 1990; 59: 77-88.
2. Strano A, Hoppensteadt D, Walenga JM et al. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease. Semin Thromb Hemost Suppl 1996; 22: 35-40.
3. Koksch M, Zeiger F, Wittig K, Pfeiffer D, Ruehlmann C. Haemostatic derangement in advanced peripheral occlusive disease. Int Angiol 1999; 18: 256-262.
4. Koksch M, Zeiger F, Wittig K et al. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease. Eur J Vase Endovasc Surg 2001; 21: 147-154.
5. Bevilacqua MP, Gimbrone MA. Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost 1987; 13: 425-433.
6. Zwaveling JH, Marin JK, Mulder AB et al. Effects of hyperthermic isolated limbperfusion with recombinant tumour necrosis factor alpha and melphlan on the human fibrinolytic system. Cancer Res 1996; 56: 3948-3953.
7. Killewich LA, Macko RF, Gardner AW, Cox K, Lilly MP, Flinn WR. Defective fibrinolysis occurs after infrainguinal reconstruction. J Vasc Surg 1997; 25: 858-865.
8. Dutch bypass oral anticoagulants or aspirin (BOA) study group, Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery: a randomised trial. Lancet 2000; 355: 346-351.
9. Tangelder MJD, Algra A, Lawson JA, Hennekes S, Eikelboom BC. Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. J Vasc Surg 2001; 33: 522-527.
10. Oostenbrink JB, Tangelder MJD, Busschbach JJV. Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. J Vasc Surg 2001; 34: 254-262.
11. Second European Consensus Document on chronic critical leg ischemia. Circulation 1991;84(suppl 4):IV 1-26.
12. Margaglione M, Grandone E, Di Minno G. Plasma predictors of ischemic complications of atherosclerosis: open issues. Biomed Pharmacother 1993; 47(10): 445-449.
13. Woodburn KR, Rumley A, Lowe GD, Pollock JG. Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia. Eur J Vasc Endovasc Surg 1995; 10: 272-278.
14. Woodburn KR, Lowe GD, Rumley A, Love J, Pollock JG. Relation of hemostatic, fibrinolytic and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995; 14: 219-225.
15. Li N, Astudillo R, Ivert T, Hjemdahl P. Biphasic prothrombotic and inflammatory response after coronary bypass surgery. J Thromb Haemost 2003; 1: 470-476.
16. Killewich LA, Gardner AW, Macko RF. Progressive intermittent claudication is assocated with impaired fibrinolysis. J Vasc Surg 1998; 27: 645-650.
17. Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999; 145: 51-60.
18. Joseph L, Fink LM, Hauer-Jensen M. Cytokines in coagulation and thrombosis: a preclindcal and clinical review. Blood Coagul fibrinolysis 2003; 13: 105-116.
19. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6 - 174g > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 2002; 22(4): 599-604.
20. Lassila R, Rossi P, Salenius JP, Lepäntalo M. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities - an association with ischemia and patient outcome. Thromb Hemost 1995; 74: 1442-1446.
21. Lehmann KG, Gonzales E, Tri BD, Vaziri ND. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilatation. Am Heart J 1999; 137: 274-283.
22. Earnshaw JJ, Westby JC, Makin GS, Hopkinson BR. Defective fibrinolysis: a risk factor in early femoropopliteal graft thrombosis. Br J Surg 1987; 74: 932-935.
23. Seyfer AE, Seaber AV, Dombrose FA, Urbaniak JR. Coagulation changes in elective surgery and trauma. Ann Surg 1993; 1981: 210-213.
24. Bevilacqua MP, Gimbrone MA. Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost 1987; 13: 425-433.
25. Ernofsson M, Tenno T, Siegbahn A. Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines. Br J Haematol 1996; 95: 249-257.
26. Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83: 307-320.
27. Pajkrt D, Van Der Poll T, Levi M, Cutler DL, Affrime MB, van den Ende A, Cate JW, van Deventer SJ. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxmia. Blood 1997; 89: 2701-2705.
28. Sarich TC, Eriksson UG, Mattsson C, Wolzt M, Frison L, Fager G, Gustafsson D. Inhibition of thrombin generation by the oral direct thrombin inhibitor ximelagatran in shed blood from healthy male subjects. Thromb Haemost 2002; 87(2): 300-305.